Your browser doesn't support javascript.
loading
Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis.
Filippatos, Gerasimos; Anker, Stefan D; August, Phyllis; Coats, Andrew J S; Januzzi, James L; Mankovsky, Boris; Rossing, Peter; Ruilope, Luis M; Pitt, Bertram; Sarafidis, Pantelis; Teerlink, John R; Kapelios, Chris J; Gebel, Martin; Brinker, Meike; Joseph, Amer; Lage, Andrea; Bakris, George; Agarwal, Rajiv.
Affiliation
  • Filippatos G; Department of Cardiology, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, Rimini 1, Chaidari 124 62, Athens, Greece.
  • Anker SD; Department of Cardiology (CVK) and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin, Berlin, Germany.
  • August P; Division of Nephrology and Hypertension, Department of Medicine, New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY, USA.
  • Coats AJS; Department of Transplantation Medicine, New York Presbyterian Hospital-Weill Cornell Medical College, New York, NY, USA.
  • Januzzi JL; Heart Research Institute, 7 Eliza Street, Sydney, Australia.
  • Mankovsky B; Massachusetts General Hospital, Harvard Medical School, and Baim Institute for Clinical Research, Boston, MA, USA.
  • Rossing P; National Healthcare University of Ukraine, Kiev, Ukraine.
  • Ruilope LM; Steno Diabetes Center Copenhagen, Herlev, Denmark.
  • Pitt B; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Sarafidis P; Cardiorenal Translational Laboratory and Hypertension Unit, Institute of Research imas12, Madrid, Spain.
  • Teerlink JR; CIBER-CV, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Kapelios CJ; Faculty of Sport Sciences, European University of Madrid, Madrid, Spain.
  • Gebel M; Department of Medicine, University of Michigan School of Medicine, Ann Arbor, MI, USA.
  • Brinker M; Department of Nephrology, Hippokration Hospital, Aristotle University of Thessaloniki, Thessaloníki, Greece.
  • Joseph A; Section of Cardiology, San Francisco Veterans Affairs Medical Center and School of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Lage A; Department of Cardiology, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, Rimini 1, Chaidari 124 62, Athens, Greece.
  • Bakris G; Department of Cardiology, Laiko General Hospital, Athens, Greece.
  • Agarwal R; Statistics & Data Insights, Bayer AG, Wuppertal, Germany.
Eur Heart J Cardiovasc Pharmacother ; 9(2): 183-191, 2023 02 02.
Article de En | MEDLINE | ID: mdl-36639130
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Diabète de type 2 / Néphropathies diabétiques / Insuffisance rénale chronique / Défaillance cardiaque Type d'étude: Clinical_trials / Diagnostic_studies / Etiology_studies Limites: Humans / Middle aged Langue: En Journal: Eur Heart J Cardiovasc Pharmacother Année: 2023 Type de document: Article Pays d'affiliation: Grèce Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Diabète de type 2 / Néphropathies diabétiques / Insuffisance rénale chronique / Défaillance cardiaque Type d'étude: Clinical_trials / Diagnostic_studies / Etiology_studies Limites: Humans / Middle aged Langue: En Journal: Eur Heart J Cardiovasc Pharmacother Année: 2023 Type de document: Article Pays d'affiliation: Grèce Pays de publication: Royaume-Uni